Welcoming John Apathy to the DataJoint Team as Strategic Advisor

We’re thrilled to share that John Apathy has joined DataJoint as a Strategic Advisor, bringing deep expertise in data-driven innovation and AI strategy in life sciences R&D.

‍
John has spent over three decades leading digital transformation across organizations like Bristol Myers Squibb, Celgene, and GlaxoSmithKline—helping research and development teams turn complex data into scientific breakthroughs. Today, as Chief Solutions Officer at XponentL Data, a Genpact company, he continues to guide organizations in making data and AI a true competitive advantage.

‍
At DataJoint, we’re on a mission to make scientific research more reproducible, integrated, and AI-ready through our SciOps platform. John’s experience will be key in helping us accelerate that mission—empowering scientists to connect instruments, data, and computation into automated workflows that drive discovery.

‍
As our CEO Jim Olson put it:

“John’s deep experience in digital and data transformation makes him an outstanding addition to our advisory team.”‍

‍

We couldn’t agree more. Welcome, John—excited to build the future of data-driven science together!